Möchten Sie immer auf dem neuesten Stand bleiben?

New York, USA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Global Active Implantable Medical Devices Market Set to Reach New Heights at a CAGR of ~7% by 2032, Driven by Rising Chronic Disease Burden and...

Announced U.S. Food and Drug Administration (FDA) Acceptance for Reviewof New Drug Application (NDA) for GTx-104 FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking...

Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and customer base expansion Gross profit margins increased 690...

New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "Data Center Maintenance and Support Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Needle-Free Devices: Technologies and Global Markets" has been added to ResearchAndMarkets.com's offering. The global market for needle-free devices...

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Repair and Reconstruction Devices Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The...

Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January Soquelitinib...

Lewes, Delaware, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Global Contraceptive Drugs Market Size is projected to grow at a CAGR of 6.16% from 2024 to 2031, according to a new report published by...

BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Today, Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, announced AI-generated risk intelligence as part of the Rapid7...